ROCKVILLE, MD, USA and SUZHOU, China I July 10, 2025 I Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing ...

MIDDLETOWN, DE, USA I July 10, 2025 I Earendil Labs, an AI-empowered biotechnology company, announced that it has completed cohort 1 dosing in a phase 1 trial ...

New indication based on results of RATIONALE-309 study demonstrating statistically significant improvement in progression-free survival ...

PALM BEACH GARDENS, FL, USA I July 10, 2025 I Eolas Therapeutics today announced that it has entered into a new agreement with AstraZeneca to assume full development rights to AZD4041, an ...

BASEL, Switzerland / MUNICH, Germany I July 10, 2025 I NUCLIDIUM, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

WALTHAM, MA, USA I July 9, 2025 I Sironax, a clinical-stage biotech company dedicated to the discovery and development of transformational therapies for ...

SHANGHAI, China I July 9, 2025 I Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative ...

Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova’s Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabetes ...

OSLO, Norway and CAMBRIDGE, MA, USA I July 9, 2025 I Actithera, a radiopharmaceutical biotech company translating medicinal chemistry insights into ...

CHICAGO, IL, USA I July 09, 2025 I MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of ...

MARTINSRIED, Germany, and MARSEILLE, France I July 10, 2025 I Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of ...